Nature’s Sunshine Products (NASDAQ:NATR) Price Target Raised to $33.00

Nature’s Sunshine Products (NASDAQ:NATR) had its price target boosted by DA Davidson from $23.00 to $33.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a buy rating on the stock.

Several other equities research analysts have also recently commented on NATR. Canaccord Genuity Group lifted their price target on shares of Nature’s Sunshine Products from $22.00 to $29.00 and gave the stock a “buy” rating in a research report on Tuesday, March 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Nature’s Sunshine Products in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $31.00.

Nature’s Sunshine Products Stock Down 2.8%

Shares of NATR opened at $24.49 on Thursday. The stock’s fifty day simple moving average is $25.10 and its 200-day simple moving average is $20.49. The firm has a market capitalization of $428.82 million, a PE ratio of 23.10 and a beta of 0.94. Nature’s Sunshine Products has a 12-month low of $11.01 and a 12-month high of $28.14.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings data on Tuesday, March 10th. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.11. The firm had revenue of $123.81 million during the quarter, compared to analyst estimates of $121.62 million. Nature’s Sunshine Products had a return on equity of 14.36% and a net margin of 4.07%.

Hedge Funds Weigh In On Nature’s Sunshine Products

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. First Trust Advisors LP grew its position in shares of Nature’s Sunshine Products by 1.7% during the 4th quarter. First Trust Advisors LP now owns 44,803 shares of the company’s stock worth $967,000 after buying an additional 736 shares during the period. Ameriprise Financial Inc. raised its position in shares of Nature’s Sunshine Products by 1.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 54,008 shares of the company’s stock valued at $799,000 after acquiring an additional 753 shares during the period. R Squared Ltd raised its position in shares of Nature’s Sunshine Products by 9.2% in the 4th quarter. R Squared Ltd now owns 14,248 shares of the company’s stock valued at $307,000 after acquiring an additional 1,199 shares during the period. CWM LLC boosted its stake in Nature’s Sunshine Products by 147.0% during the 3rd quarter. CWM LLC now owns 2,075 shares of the company’s stock worth $32,000 after acquiring an additional 1,235 shares during the last quarter. Finally, Strs Ohio boosted its stake in Nature’s Sunshine Products by 4.2% during the 3rd quarter. Strs Ohio now owns 35,100 shares of the company’s stock worth $545,000 after acquiring an additional 1,400 shares during the last quarter. Institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.